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Bladder tumours show a variable response to radiotherapy with only about 50% showing good local control; currently there is no test
to predict outcome prior to treatment. We have used five bladder tumour cell lines (T24, UM-UC-3, TCC-SUP, RT112, HT1376) to
investigate the potential of the alkaline comet assay (ACA) to predict radiosensitivity. Radiation-induced DNA damage and repair
were compared to clonogenic survival. When the five cell lines were irradiated and initial DNA damage was plotted against cell
survival, at all doses (0–6Gy), a significant correlation was found (r
2¼0.9514). Following 4Gy X-irradiation, all cell lines, except T24,
showed a correlation between SF2 vs half-time for repair and SF2 vs residual damage at 5, 10, 20 and 30min. The T24 cell line
showed radioresistance at low doses (0–2Gy) and radiosensitivity at higher doses (4–6Gy) using both cell survival and ACA end
points, explaining the lack of correlation observed for this cell line. These data indicate that initial DNA damage and residual damage
can be used to predict for radiosensitivity. Our data suggest that predictive tests of radiosensitivity, appropriate to the clinical
situation, may require the use of test doses in the clinical range.
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West and colleagues have shown that biopsies from cervix and
head and neck tumours can be used to predict for an individual
patient’s response to radiotherapy using clonogenic cell survival
following exposure to 2Gy X-irradiation (West et al, 1997;
Bjork-Eriksson et al, 2000). The main disadvantages of this assay
are that a minimum of 4 weeks is required to obtain a result, and
about 30% of excised tumours failed to grow in soft agar; success
of this method in other tumour types has been elusive.
The limitations of this assay have stimulated an interest in
developing methods that might provide a quicker, and more
reliable, measure of tumour radiosensitivity so that results could
be considered in treatment planning; to date no satisfactory test
has been reported.
A number of studies have investigated the utility of the neutral
comet assay (NCA) as a predictive method for radiosensitivity with
varying results. Olive et al, (1994) showed no correlation with
radiosensitivity for six human tumour cell lines of different
origins, whereas a reasonable correlation has been reported in two
studies when the cell lines used were of the same tissue of origin,
that is, cervix (Marples et al, 1998) and bladder (Price et al, 2000).
However, Woudstra et al (1998), using the related methods of
pulse field gel electrophoresis (PFGE) and the halo assay, could not
show correlation, using 10 human tumour cell lines of different
tissue origins. One particular drawback of the NCA, and many of
the other DSB assays is that, for reasons of poor sensitivity, they
are carried out at doses well outside the clinically relevant range
(approximately 20–150Gy). This makes comparison of the results
to clonogenic assays, normally carried out between 0 and 10Gy
problematic.
The alkaline comet assay (ACA) has several attractive features
for a predictive test of radiosensitivity: it is simple and quick to do,
it does not require clonogenic cell growth as it is carried out on
single-cell suspensions from primary tumours and effects can be
measured in the clinically relevant dose range (0–6Gy). All of
these criteria are essential if a predictive test is to have practical
utility in a clinical context. Although there are many studies in the
literature on the value of the ACA in the assessment of
radiosensitivity, the majority are on normal cells, for example,
lymphocytes or fibroblasts. Investigation of the utility of the ACA
for determining tumour cell radiosensitivity has been limited to a
few studies, often comparing cells from a range of tumours types
(Table 1). Previously, we have reported a preliminary study of
three cell lines derived from transitional cell carcinoma (TCC) of
the bladder. Cells were exposed to 0–10Gy X-rays and an inverse
correlation between cell survival (clonogenic assay) and mean tail
moment (ACA) was observed (McKelvey-Martin et al, 1998). This
supported the hypothesis that the ACA might be useful in
predicting the radioresponsiveness of individual cell lines. Here,
we report results in five bladder cancer cell lines using a modified,
more sensitive, version of the ACA. Our results are further
supported by two independent studies using colorectal tumour
cells (Dunne et al, 2003) and bladder tumour cells (Moneef et al,
2003).
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yMATERIALS AND METHODS
Cell lines and culture
Five mycoplasma-free bladder cell lines, derived from high-grade
TCCs were used in this study (UM-UC-3, RT112, HT1376, TCC-
SUP and T24; American Tissue Culture Collection). All of the cell
lines, except T24, were maintained in exponential growth in Eagle’s
minimal essential medium (EMEM), supplemented with 2mM l-
glutamine, 25mM sodium bicarbonate, 10% foetal calf serum
(FCS), 1% nonessential aminoacids, 1% penicillin–streptomycin;
for UM-UC-3 cells 1% sodium pyruvate was also added. The T24
cell line was grown in McCoy’s medium supplemented as above.
Doubling times of the cell lines were between 20h (UM-UC-3) and
36h (HT1376). Cells were harvested at 80–90% confluence.
X-ray irradiation for comet assays
Cells were irradiated either on slides or in Eppendorf tubes at 41C
using a Siemans Stabilipan X-ray machine operated at 300kV at a
dose rate of 2.6Gymin
 1. Repair studies were performed by
irradiating preembedded cells on crushed ice; slides were then
placed in ice-cold lysis buffer (control) or in growth medium at
371C in 95% air: 5% CO2 for specified times prior to lysis.
Alkaline Comet Assay
The Eppendorf method was performed using a protocol developed
by Singh et al (1988). Briefly, Dakin fully frosted slides were
covered with 300ml of 0.75% normal melting point agarose (NMP),
dissolved in PBS at 451C, coverslips were added and the agarose
allowed to solidify. Cells (10
5) in 1ml culture medium were
irradiated in Eppendorf tubes on ice before centrifugation at 41C
for 5min at 1200r.p.m. The coverslips were removed and 89mlo f
0.75% low melting agarose (LMP), dissolved in PBS at 371C, was
added to each pellet (0.11ml); the final concentration of agarose
was 0.67%. The cell/agarose suspension was used to form the
second layer and allowed to solidify under a fresh coverslip at
room temperature for 5min. The embedded cells, with coverslips
removed, were then placed at 41C in cold lysis buffer (2.5 M NaCl,
100mM Na2EDTA, 10mM Tris, pH 10 and 1% Triton X-100 added
fresh). After 1h, slides were drained and placed in a horizontal gel
electrophoresis unit containing fresh chilled electrophoresis buffer
(300mM NaOH and 1mM Na2EDTA, pH 13.0) to a level of
approximately 0.25cm above the slides. Slides were kept in this
buffer for 20min to allow unwinding of the DNA. Electrophoresis
was carried out for 20min at 25V (0.83Vcm
 1). Slides were
drained, placed on a tray and flooded slowly with three changes of
neutralisation buffer (0.4 M Tris pH 7.5) each for 5min. Slides were
stained with 50ml of ethidium bromide (20mgml
 1) and covered
with a coverslip for immediate analysis. All the steps were
conducted under yellow light to prevent additional DNA damage
by natural light. Analysis was carried out on 25 cells/slide, two
slides per dose/time point, that is 50 values per point; each
experiment was carried out on three separate occasions.
The slide method is a modification of the Eppendorf method to
allow irradiation of cells after embedding in low melting point
(LMP) agarose. Briefly, 95ml of 0.6% NMP agarose, in RPMI
medium, was allowed to solidify on Dakin slides (as above). Equal
volumes of cell suspension (2 10
5cellsml
 1 and 1.2% LMP
agarose (in RPMI medium containing 10% FCS, at 371C) were
mixed. A volume of 75ml of this second layer was quickly pipetted
on to the NMP agarose-coated slides and allowed to solidify under
a coverslip for 5min on ice. Coverslips were removed and the
slides were irradiated (0–6Gy) on ice. The slides were immediately
immersed in ice-cold lysis buffer and the remaining steps were as
described above. We confirmed that the difference in LMP agarose
concentration for the two methods (0.67 vs 0.6%) had no
significant effect on tail moment (unpublished data).
Cells were analysed using Hewlett Packard Super VGA and
Fenestra Komet Software (version 3) (Kinetic Imaging Ltd.).
Observations were made at a magnification  400 using an epi-
fluorescence microscope (Olympus BH2) equipped with an
excitation filter of 515–535nm, 100W mercury lamp and a barrier
filter at 590nm. Several parameters of each cell were calculated by
the software package, and tail moment was selected as the
parameter that best reflected DNA damage. Tail moment is
defined as tail length multiplied by the percent tail DNA, where tail
length is defined as comet length minus head length.
Clonogenic assay
Single cell suspensions were counted and seeded in appropriate
numbers in 60 15mm Petri dishes (Falcon) with 6ml appropriate
culture media. Following a 4h incubation at 371C, cells were
irradiated at 2, 4, 6, 8 and 10Gy; unirradiated cells were processed
in parallel. Cells were then incubated at 371C, in a humidified 95%
air, 5% CO2 for 2 weeks, stained with crystal violet and colonies (50
or more cells) were counted. Three replicates were prepared for
each control and dose group, and each experiment was performed
on three separate occasions. For each cell line, the plating
Table 1 Studies using the ACA to measure DNA damage and repair in tumour cells following exposure to X-irradiation
Radiation Dose range/time of repair study
Reference Sample ID
a Repair Main conclusions
Olive et al (1990) Mouse tumour cells (*SCC VII)
and tumour-derived macrophages
0–15Gy 15Gy
0–30min
ID: increased linearly with dose,
similar in normal and tumour cells
Repair: no difference
Mu ¨ller et al (1994) Human SCCs (PECA 4451, PECA 4197),
human melanoma (MeWo)
0–2Gy 5Gy
0–120min
ID: no correlation
Repair: Some correlation
McKelvey-Martin et al (1998) Three human bladder tumour cell lines
(RT112, UM-UC-3, HT1376)
0–10Gy ND ID: inverse correlation SF2 and
tail moment
Bergqvist et al (1998) Four human lung tumour cell lines
(U-1285, U-1906E, U-1752, U-1810)
0–5Gy 0–5Gy
60min
ID: No correlation with SF2
RD: some correlation at 60min
Bachova et al (2002) Three human ovarian tumour cell lines
(CH-1, A-2780, SKOV-3)
0, 2, 8Gy 2 and 8Gy
0–90min
ID: correlation with apoptosis
Repair rate: no correlation
RD: some correlation at 30min
aSCC¼squamous cell carcinoma; ID¼initial damage; RD¼residual damage; ND¼not determined.
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yefficiency (PE) for untreated cells was determined (this was 435%
for all cell lines). The surviving fraction (SF) was defined as the
ratio of colonies produced to cells plated, with a correction for PE.
SF¼colonies counted/cells seeded (PE/100).
Statistical analysis
Standard errors for individual results were calculated from three
means derived from individual replicate experiments. To deter-
mine significance, data were subjected to one factor ANOVA (P-
values o0.05 were considered significant). To derive correlation
coefficients, a linear curve fit was applied to the data for all cell
lines excluding T24. The data for T24 were omitted as this cell line
clearly changes its sensitivity to radiation over the range 2–4Gy;
therefore, repair at 4Gy cannot be compared to the SF2 which is
measured at 2Gy (see Discussion below).
RESULTS
Radiation survival curves for the five bladder cancer cell lines are
shown in Figure 1, with the surviving fraction at 2Gy (SF2) in
Table 2. The cell lines encompass a range of sensitivities with
HT1376 being the most radioresistant cell line and UM-UC-3 the
most radiosensitive. T24 showed a shallow shoulder on the
survival curve leading to a radioresistant response at low doses;
however, there was a greater rate of change of radiosensitivity
above 2Gy, which lead a radiosensitive response at higher doses.
This result has been confirmed by Moneef et al (2003).
DNA damage following irradiation was measured in three cell
lines using both the Eppendorf and slide variants of the ACA.
Reproducible dose–response curves for mean tail moment were
obtained, with the radiosensitive cell line (UM-UC-3) displaying
the greatest DNA damage and the radioresistant cell line (HT1376)
displaying the least (Figure 2). The slide version of the comet assay
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Figure 1 Survival of T24, UM-UC-3, TCC-SUP, RT112 and HT1376
cells. Cell survival was measured as the number of colonies formed
following X-ray irradiation at 0–10Gy. Each data point is the mean7s.e. of
three separate experiments. Each experiment contained three replicates.
Error bars are shown only when they exceed the size of the symbol.
Table 2 Repair of DNA damage in five bladder cancer cell lines
following exposure to X-irradiation
Cell Line SF2
a
Residual
damage
(30min)
b
Residual
damage
(60min)
b T1/2
c (min)
T24 0.7070.01 4.3870.25 2.3170.37 8.8
UM-UC-3 0.5970.03 1.0670.07 0.3470.02 5
TCC-SUP 0.6270.02 0.8470.01 0.1870.02 4
RT112 0.6770.01 0.5070.03 0.0070.002 3.0
HT1376 0.7770.07 0.0070.002 0.0070.002 2.5
aSurviving fraction of cells exposured to 2Gy, determined by performing three
independent experiments each containing three replicates.
bResidual DNA damage
calculated by subtracting the control tail moment from that remaining at 30 and
60min in Figure 5.
cTime (min) for half of the initial damage to be repaired. The data
represent the mean7s.e. of three independent experiments.
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Figure 2 DNA damage in UM-UC-3, RT112 and HT1376 cells using the
Eppendorf and slide ACA. Cells were irradiated on ice. DNA damage was
measured as tail moment. Data points represent the mean7s.e. from three
independent experiments. Error bars are shown only when they exceed
the size of the symbol.
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DNA damage. The level of background damage in unirradiated
controls for individual cell lines was similar (tail momentD0.40).
The Eppendorf method gave a significant difference (Po0.01, one
factor ANOVA) in tail moment between different cell lines for
radiation doses of 4Gy and above; the slide method revealed a
significant difference at 1Gy (Po0.05, one factor ANOVA).
When the five cell lines are compared using the slide comet
assay, the radiosensitive lines (e.g. UM-UC-3) showed the greatest
DNA damage and the radioresistant lines (e.g. HT1376) displayed
the least damage (Figure 3). Figure 4 shows mean tail moment for
initial damage (0–6Gy) plotted against log cell survival (data from
all five cell lines) and a significant correlation is found
(r
2¼0.9514). This suggests that, at low clinically relevant doses,
the ACA could be used to predict cell survival.
Repair of DNA damage was examined by incubating the cells at
371C for up to 1h after exposure to 4Gy X-rays (Figure 5). The
time taken to repair half the initial DNA damage (Table 3) showed
a poorer correlation with SF2 (r
2¼0.769). By 45–60min, repair
was either complete or occurring at a much slower rate than
initially. The extent of repair/residual damage at all time points (5,
10, 20 and 30min) correlates well with SF2 (Tables 2 and 3); the
correlation is most significant at 30min r
2¼0.99 (Table 3,
Figure 6).
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Figure 3 DNA damage in T24, UM-UC-3, TCC- SUP, RT112 and
HT1376 cells. DNA damage was measured by mean tail moment using the
slide comet assay. Cells were irradiated at 0–6Gy on ice. Data points
represent the mean7s.e. from three independent experiments. Error bars
are shown only when they exceed the size of the symbol.
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Figure 4 Correlation between cell survival and mean tail moment
following exposure to 0–6Gy irradiation in T24, UM-UC-3, TCC-SUP,
RT112 and HT1376 cells. Cell survival was determined using a clonogenic
assay, tail moment was measured using the comet assay (slide method).
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Figure 5 DNA repair in T24, UM-UC-3, TCC-SUP, RT112 and HT1376
cells after exposure to 4Gy X-rays. Data points represent the mean7s.e.
from three independent experiments. Error bars are shown only when they
exceed the size of the symbol.
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yDISCUSSION
The ability to predict the radiosensitivity of individual tumours
has long been the ‘holy grail’ of radiation biology (Lehnert, 2000).
In this paper, we present data showing that the ACA can be used as
a surrogate measure in the prediction of tumour cell radio-
sensitivity; the results are supported by two further papers (Dunne
et al, 2003; Moneef et al, 2003).
Prior to using the ACA, we attempted to measure radio-
sensitivity in 24 primary bladder tumours using the soft agar
clonogenic assay of West et al (1997). However, the success rate
was very low (8%), this was attributed to the problem of achieving
prolonged cell growth in this assay. The ACA offers an alternative
method for detecting radiosensitivity, and is attractive as a
potential clinical test as it requires a small number of cells and
results can be available within a few hours (Fairbairn et al, 1995).
In many studies using the ACA cells have been irradiated in
Eppendorf tubes prior to analysis. We used this method in a
preliminary study (McKelvey-Martin et al, 1998) when well-
defined radiation dose-response curves were observed with the
greatest initial DNA damage displayed by the radiosensitive cell
line (UM-UC-3) and the least by the radioresistant cell line
(HT1376). However, it was difficult to determine the extent of DNA
damage at low, clinically relevant, radiation doses (1–2Gy). We
have increased the sensitivity of the assay by embedding the cells
in agarose prior to irradiation at 01C; slides can then be placed in
ice-cold lysis solution immediately following irradiation. Since
radiation-induced DNA damage is repaired very rapidly (t1/2B2–
5min; Table 2), it is inevitable that some repair will occur if cells
are embedded in warm agarose after irradiation (Figure 2). Even if
preembedded cells are irradiated (0–6Gy) at room temperature, as
compared to on ice, a smaller tail moment is obtained (our
unpublished data); this supports the contention that every effort
must be made to minimise repair during radiation exposure and
up to the time of lysis. It is therefore critical that cells are
preembedded and cooled on ice for any study using the ACA to
measure initial radiation-induced DNA damage. With this
modification, cell lines of different SF2 values could be separated
using doses above 1.0Gy. Recently, it has been shown that the half-
life of repair of human head and neck tumours is about 4min,
showing that the rate of DNA repair following irradiation of
human tumours in situ is of a similar order of magnitude to that in
vitro (Terris et al, 2002).
Since the main aim of this study is to find a surrogate for the
overall biological response in an individual tumour, the composite
of factors that contribute to this cellular radiosensitivity should be
reflected by the response measured. Of particular importance is
our observation that the tail moment measured immediately after
radiation exposure correlated with radiation dose (Figure 3) and
can predict for cell survival in the clinically relevant range
(Figure 4; r
2¼0.9514). Even the T24 cell line, which has a
significantly more pronounced shoulder on the cell survival curve,
shows good agreement between the two measures. It can be seen
from the studies summarised in Table 1 that there has been
surprisingly few similar studies of tumour cells using the ACA.
Olive et al (1990) used the ACA to compare the radiosensitivity of
infiltrating macrophages with tumour cells in a mouse tumour
model; no differences in the cell populations was observed. Our
initial study (McKelvey-Martin et al, 1998) did show correlation
(see above) and this is supported by a study in three ovarian
tumour cell lines (Bacova et al, 2000). Two studies do not support
our findings, however they irradiated the cells prior to embedding
thus reducing the sensitivity of their procedure (Muller et al, 1994;
Bergqvist et al, 1998). In addition, our study has been confirmed
by the concurrently presented studies of bladder tumour cells
(Moneef et al, 2003) and colorectal tumour cells (Dunne et al,
2003) suggesting that the method is robust and reproducible in
different tumour types and different laboratories. Indeed, it may be
that our version of the ACA is capable of exposing differences that
are masked in other variants of the same assay.
In contrast to the paucity of studies on SSBs there have been
many studies using a range of assays to measure DSBs. The
rationale for these investigations has been the general agreement
that DSBs are the most critical of DNA-damaging lesions (Ward,
1988). However, the studies have shown little agreement as to
whether initial DSBs vary between cell types. For example, in one
review of 29 studies of neutral filter elution and neutral gel
electrophoresis no consensus was found as to the correlation of
survival with initial DSBs and rejoining (Olive et al, 1994). In a
comparison of radiosensitive and radioresistant tumour cells using
PFGE, the ACA and the halo assay, only the halo assay showed
differences in initial damage. It was suggested, however, that the
presentation of the DNA damage in the three assays might explain
the differences (Woudstra et al, 1996). Chromatin structure, and
its response to assay conditions, have also been implicated in
responses observed with the halo DNA damage assay (Malyapa
et al, 1994, 1996). A major drawback of the NCA, and other
methods carried out under neutral conditions, is the lack of
sensitivity of these assays, necessitating the measurement of DSBs
Table 3 Correlation coefficients obtained when SF2
a is plotted against
initial DNA damage (0min), and remaining damage at a range of repair
times (5–30min)
Repair time Correlation coefficient (r
2)
b
0min 0.974
5min 0.976
10min 0.967
20min 0.938
30min 0.993
T1/2
c 0.769
aSF2¼the fraction of clonogenic cells surviving following 2Gy X-irradiation.
bCorrelation coefficient calculated from plots of SF2 against DNA damage 0–
30min following X-irradiation at 4Gy. that is, residual   control damage/
initial control damage at time points 5–30min for each cell line, except T24. A
linear curve fit was applied and the correlation coefficient calculated.
cT1/2 ¼time
point when half the initial damage (adjusted for background level) has been repaired.
Residual DNA damage calculated by subtracting the control tail moment from that
remaining at each time point in Fig. 5.
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Figure 6 Correlation between SF2 and residual damage 30min/initial
damage following 4Gy X-rays for the UM-UC-3, TCC-SUP, RT112 and
HT1376 cell lines. Error bars are not shown on these graphs; they are
included in Table 2.
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essentially kill all the cells. However, a number of factors can
influence cell survival following radiation exposure, and the
studies of Malaise et al (1987) and Deacon et al (1984) suggest
that for a predictive test of radiosensitivity the measurements must
be made at doses o6Gy. Therefore studies of DSBs, although
useful in understanding physico-chemical effects of radiation on
DNA, have less utility in defining clinically relevant parameters.
Indeed, it could be argued that assays of SSBs can be used as a
surrogate for DSBs although direct evidence of this assumption is
inferred rather than proven; several authors quote an implied
linear ratio of DSBs to SSBs, for example, Olive and Johnston
(1997). However, we propose that this assumption may be a better
basis for evaluation of cellular radiosensitivity at low doses (2–
4Gy) and it may ultimately provide a predictive test that can be
translated to the clinic, we are currently investigating this.
The literature on the correlation of DNA damage and
clonogenicity is confusing. Differences in initial damage appear
to depend primarily on both the assay and the specific conditions
used in a particular laboratory. Many studies have used cells of
different species and tissue origins and attempted to make direct
comparison of radioresponsiveness; this may also result in
misleading conclusions. For example, studies on fibroblasts tend
to show a more limited, if any, difference in initial damage, a
finding with which we would concur (our unpublished data).
There is currently limited data available to explain the reason(s)
for this variation and we can only speculate that differences in
chromatin structure, antioxidant and thiol levels may all have a
role to play (Kapiszewska et al, 1992; Woudstra et al, 1996; Mateos
et al, 1998; McMillan et al, 2001). One group have suggested that
initial damage, as measured in the halo assay and ACA, may not
reflect overt strand breaks, but a loosening of chromatin structure
which may vary between cell lines (Malyapa et al, 1994, 1996). In a
recent study (Rajab, 2002), it has been shown that nuclear texture,
which may reflect differences in chromatin structure/organization,
also correlates with radiosensitivity in bladder cancer cells.
Whatever the explanation, it seems that some cells clearly have
more disruption to their chromatin when irradiated than others.
This seems to put a greater strain on the cell’s repair capacity
since, although the repair rates vary less, the time to return to
background levels is longer for cells that have greater initial
damage (Table 2; Figure 5; see also Moneef et al (2003).
When the ability to repair DNA damage following X-irradiation
was compared to SF2, the cell lines maintained the same rank
order as in the clonogenic assay (Figure 5). Although the time to
repair half the initial damage was slower in radiosensitive cells, the
differences were less significant (r
2¼0.769). The damage remain-
ing at 30min compared to SF2 also correlated very well for all cell
lines (r
2¼0.993; Figure 6). Again repair and radiosensitivity have
been found to correlate in some studies but not others. For
example Daza et al (1997) have shown that although initial SSBs
varied with radiosensitivity, initial DSBs and repair did not (using
PFGE). Initial damage therefore appears to have a greater influence
on a cell’s overall response to radiation, and there appears to be
some limitation in the capacity of the cells to repair at the initially
rapid repair rate. This leaves those cell types with greater initial
damage also with a greater residual damage as the second, slower
repair phase, becomes dominant. As a consequence, the radio-
sensitive cells are left with ‘residual’ DNA damage for a much
longer period than the resistant cells. It should be noted that T24
cells were excluded from the correlations of repair since they
clearly change their radioresponsiveness between 2 and 4Gy. On
reflection, it might have been better to carry out the repair study at
2Gy; this was not carried out because the differences in tail
moment between the cell lines, although significant, were not large
enough to follow repair for more than a limited time period.
However, it now seems clear that initial damage is the most useful
parameter and provides the best (and incidentally the easiest)
surrogate measure of radiosensitivity.
Initially, the T24 cell line had a shallow survival curve, however,
there was a much greater rate of change in radiosensitivity between
2.0 and 4.0Gy making comparison of the SF2 with repair at 4Gy
problematic. However, this ‘problem’ can also be seen as a
potential advantage. The change from resistant to sensitive
phenotype in both assays, supports our contention that one assay
predicts for the other. In addition, the influence of the position and
change in the shoulder of the survival curve underlines the
importance of carrying out predictive tests at clinically relevant
doses. Clearly, for some tumours the wrong conclusion could be
arrived at if radiosensitivity is predicted using a dose, even a few
Gy, above that used in the clinic. This conclusion also concurs with
seminal studies of Malaise et al (1987) and Deacon et al (1984),
updated by Steel (1996) in which they provide considerable
evidence that the radiosensitivity of tumours is most reliably
measured at 2Gy. The clinical studies of West and colleagues
would support this proposition (West et al, 1997; Bjork-Eriksson
et al, 2000).
In conclusion, although many studies have used the comet assay
to measure radiation induced DNA damage and repair, there are
only very few that have used ACA to compare several tumour cell
lines of the same tissue origin. Studies on tumour cells,
lymphocytes and fibroblasts are rather contradictory and this
may indicate that there are differences in the DNA conformation
and sensitivity to radiation in cells of different origins. We have
attempted to avoid this problem by restricting ourselves to bladder
tumour cells; a second parallel study, using our method and
restricted also to bladder tumour cells, confirms our findings
(Moneef et al, 2003), as does a study of colorectal tumours (Dunne
et al, 2003). Although a complete understanding of the factors
underlying the responses measured eludes us the repetition of this
study in two other situations/laboratories suggests that, with our
method, we can measure differences in cellular responses to
radiation that can predict for tumour cell survival in a clinically
relevant dose range. We consider that the evidence is now sufficient
to compare the radiosensitivity of biopsy samples from human
bladder tumours using initial damage at 2Gy as the simplest and
most reliable measure. A preliminary clinical trial is currently being
carried out by Dr Jones and colleagues in Leicester, UK.
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